Therapy News and Research

RSS

Study examines HIV-positive patients' death risk at CD4 counts above 350

"Having HIV appears to be associated with a greater risk of death, even when the immune system is relatively robust and patients have not started treatment," according to a study published Friday in the Lancet, MedPage Today reports (Smith, 7/15).

17 Jul 2010

Epizyme publishes two new review papers on epigenetics

Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, announced today the publication of two new review papers in the area of epigenetics. Together, the articles provide an overview of the major epigenetic enzyme classes, as well as chemical biology approaches for discovering small molecule inhibitors of these epigenetic enzymes, and demonstrate Epizyme's scientific leadership in the area of epigenetics.

17 Jul 2010

Amgen granted FDA priority review designation for denosumab BLA

Amgen today announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.

17 Jul 2010

94 indicted in five-state crackdown on Medicare fraud

Law enforcement officers fanned out across five states Friday in what federal officials called the largest Medicare fraud bust ever conducted. Nearly 100 people were indicted in frauds that totaled $251 million.

17 Jul 2010

An overview of AAPM annual meeting

AAPM is the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology. Its membership includes medical physicists who specialize in research that develops cutting-edge technologies and board-certified clinical medical physicists who apply these technologies in community hospitals, clinics, and academic medical centers.

16 Jul 2010

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Next week the city of Philadelphia will host the 52nd annual meeting of the American Association of Physicists in Medicine (AAPM), the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology.

16 Jul 2010

Treatment admissions for abuse of prescription pain relievers increases by over 400%: Study

The proportion of all substance abuse treatment admissions of those aged 12 and older involving abuse of prescription pain relievers rose by over 400 percent from 2.2 percent in 1998 to 9.8 percent in 2008 according to a new study be the Substance Abuse and Mental Health Services Administration (SAMHSA). This dramatic rise in the proportion of admissions associated with the abuse of these drugs occurred among nearly all segments of the population regardless of age, gender, educational level and employment status.

16 Jul 2010

Bioethics through the lens of literature

What if I were grown only so that my organs could be harvested, and I had to care for others whose organs are being taken, too, while I wait for my own death? What if doctors cut off a piece of the tumor that killed me and grew it in a lab for the next sixty years? What if scientists discovered a gene that would ensure my happiness no matter what life throws at me?

16 Jul 2010

Active family engagement is important for recovery from substance abuse, chemical dependency

Active family engagement and commitment is one of the most underappreciated aspects of recovery from substance abuse and chemical dependency, according to clinical staff at Timberline Knolls Residential Treatment Center, a leading eating disorder and addiction treatment center.

16 Jul 2010

Initial sponsors of 2nd International Symposium on MR-guided Focused Ultrasound announced

The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.

From Elekta 16 Jul 2010

New research reports evaluating nephrology market in Europe released

BioTrends Research Group, Inc. has released two new syndicated market research reports evaluating the nephrology market in Europe. The reports, TreatmentTrends: Renal Anemia and TreatmentTrends: Bone and Mineral Metabolism, are derived from the responses of over 200 European nephrologists polled in May and June, 2010 regarding their approach to managing renal anemia and bone and mineral disturbances in their dialysis and chronic kidney disease patients.

16 Jul 2010

AAOS releases evidence-based clinical practice guideline for treating glenohumeral joint osteoarthritis

The American Academy of Orthopaedic Surgeons has approved and released an evidence-based clinical practice guideline on "The Treatment of Glenohumeral Joint Osteoarthritis." This major joint in the shoulder - the ball and socket joint - is sometimes affected by osteoarthritis, causing pain, loss of function, and reduced quality of life.

16 Jul 2010

MD Anderson Cancer Center continues to rank first in cancer care

The University of Texas MD Anderson Cancer Center remains the leading hospital in the nation for cancer care for the fourth year straight, according to the annual "Best Hospitals" survey published by U.S. News & World Report.This is the seventh time in the last nine years that MD Anderson has ranked number one in the annual listing. Since the survey began in 1990, the institution has been ranked one of the top two cancer hospitals in the United States.

16 Jul 2010

Diamyd Medical receives US Federal Trade Commission's antitrust clearance

Diamyd Medical AB has received antitrust clearance that closes the transaction announced on June 22, 2010 with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company.

16 Jul 2010

Neurologists more aware of Merck Serono/EMD Serono's oral cladribine than Novartis/Mitsubishi Tanabe's FTY-720

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed neurologists have low awareness of Novartis/Mitsubishi Tanabe's FTY-720 (Gilenia) among the surveyed oral emerging therapies for the treatment of multiple sclerosis (MS).

16 Jul 2010

Twin Cities Orthopedics opens new medical facility to help orthopedic patients

To help orthopedic patients receive a full range of care under one roof, Twin Cities Orthopedics today is opening a new state-of-the-art medical facility in Edina.

16 Jul 2010

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

The Children's Hospital and the University of Colorado Hospital have finalized an agreement to jointly establish a center for advanced maternal fetal medicine offering state-of-the-art care for high-risk pregnant women and their babies. The two leading academic medical centers have individually provided such services for more than three decades, and by building on already existing adult and pediatric expertise, they together will be able to provide unparalleled care and treatment for the region's most at-risk moms and babies.

16 Jul 2010

New study finds no evidence in support of LTPP's superiority over shorter-term methods of psychotherapy

This paper criticizes the methodology of a meta-analysis and 8 studies published in the JAMA last year which indicated that longer term psychodynamic psychotherapy (LTPP) was more effective than short therapies. The investigators found a miscalculation of the effect sizes used to make key comparisons and found no evidence to support claims of superiority of LTPP over shorter-term methods of psychotherapy.

16 Jul 2010

Arsenic nanoparticle to combat aggressive type of breast cancer prevalent in young women

You can teach an old drug new chemotherapy tricks. Northwestern University researchers took a drug therapy proven for blood cancers but ineffective against solid tumors, packaged it with nanotechnology and got it to combat an aggressive type of breast cancer prevalent in young women, particularly young African-American women.

16 Jul 2010

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Meningiomas, the most common type of brain tumors, are rarely cancerous and may not require treatment. The July issue of Mayo Clinic Health Letter offers an overview of this brain tumor that is usually benign.

16 Jul 2010

Therapy News and Research

Study examines HIV-positive patients' death risk at CD4 counts above 350

Epizyme publishes two new review papers on epigenetics

Amgen granted FDA priority review designation for denosumab BLA

94 indicted in five-state crackdown on Medicare fraud

An overview of AAPM annual meeting

Philadelphia to host 52nd annual meeting of American Association of Physicists in Medicine

Treatment admissions for abuse of prescription pain relievers increases by over 400%: Study

Bioethics through the lens of literature

Active family engagement is important for recovery from substance abuse, chemical dependency

Initial sponsors of 2nd International Symposium on MR-guided Focused Ultrasound announced

New research reports evaluating nephrology market in Europe released

AAOS releases evidence-based clinical practice guideline for treating glenohumeral joint osteoarthritis

MD Anderson Cancer Center continues to rank first in cancer care

Diamyd Medical receives US Federal Trade Commission's antitrust clearance

Neurologists more aware of Merck Serono/EMD Serono's oral cladribine than Novartis/Mitsubishi Tanabe's FTY-720

Twin Cities Orthopedics opens new medical facility to help orthopedic patients

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

New study finds no evidence in support of LTPP's superiority over shorter-term methods of psychotherapy

Arsenic nanoparticle to combat aggressive type of breast cancer prevalent in young women

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News